Armistice Capital »

Remitly Global shares owned by Armistice Capital

Quarter-by-quarter ownership of Remitly Global (RELY) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Remitly Global

Tip: Access up to 7 years of quarterly data

All positions including Remitly Global held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Remitly Global by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $435k 21k 20.74

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Remitly Global

Naspers
Vanguard Group
Baillie Gifford & Co
Jpmorgan Chase & Co
BlackRock
Generation Investment Management
Cadian Capital Management
Wellington Management Company
FMR
Geode Capital Management
Arrowpoint Asset Management
Citadel Advisors
Lord, Abbett & Co
Massachusetts Financial Services
Millennium Management

View all funds holding Remitly Global